These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2799279)

  • 1. IFCC Guidelines to the Evaluation of Drug Effects in Clinical Chemistry. Data banks.
    Scand J Clin Lab Invest Suppl; 1989; 195():22-4. PubMed ID: 2799279
    [No Abstract]   [Full Text] [Related]  

  • 2. IFCC Guidelines to the Evaluation of Drug Effects in Clinical Chemistry. The basic concepts.
    Scand J Clin Lab Invest Suppl; 1989; 195():5-6. PubMed ID: 2678422
    [No Abstract]   [Full Text] [Related]  

  • 3. International Federation of Clinical Chemistry (IFCC). Scientific Committee, Clinical Section. Expert Panel on Drug Effects in Clinical Chemistry (EPDECC). IFCC Document stage 2, draft 3, 1983-11 with a proposal for an IFCC recommendation. Drug effects in clinical chemistry. Part 2. Guidelines for evaluation of analytical interference.
    Clin Chim Acta; 1984 May; 139(2):223F-230F. PubMed ID: 6733933
    [No Abstract]   [Full Text] [Related]  

  • 4. International Federation of Clinical Chemistry (IFCC) Scientific Committee: drug interferences and drug effects in clinical chemistry. Part 7. Data banks.
    Tryding N; Galteau MM; Salway JG; Breuer J; Malya PA; Siest G
    J Clin Chem Clin Biochem; 1987 Mar; 25(3):191-4. PubMed ID: 3598473
    [No Abstract]   [Full Text] [Related]  

  • 5. International Federation of Clinical Chemistry (IFCC). Scientific Committee, Clinical Section. Expert Panel of Drug Effects in Clinical Chemistry (EPDECC). IFCC Document stage 2, draft 3, 1983-11 with a proposal for an IFCC recommendation. Drug effects in clinical chemistry. Part 1. The basic concepts.
    Clin Chim Acta; 1984 May; 139(2):215F-221F. PubMed ID: 6733932
    [No Abstract]   [Full Text] [Related]  

  • 6. Guidelines for evaluation of analytical interference.
    Scand J Clin Lab Invest Suppl; 1989; 195():7-9. PubMed ID: 2799280
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of biological effects of drugs.
    Scand J Clin Lab Invest Suppl; 1989; 195():10-2. PubMed ID: 2678421
    [No Abstract]   [Full Text] [Related]  

  • 8. IFCC Guidelines to the Evaluation of Drug Effects in Clinical Chemistry.
    Scand J Clin Lab Invest Suppl; 1989; 195():1-29. PubMed ID: 2799275
    [No Abstract]   [Full Text] [Related]  

  • 9. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Clinical Section. The theory of reference values. Part 2. Selection of individuals for the production of reference values.
    PetitClerc C; Wilding P
    J Clin Chem Clin Biochem; 1984 Feb; 22(2):203-8. PubMed ID: 6716061
    [No Abstract]   [Full Text] [Related]  

  • 10. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Analytical Section, Expert Panel on Analytical System, Expert Panel on Enzymes. Guidelines (1987) for classification, calculation and validation of conversion rates in clinical chemistry.
    Bechtler G; Haeckel R; Hørder M; Küffer H; Porth AJ
    J Clin Chem Clin Biochem; 1987 May; 25(5):315-25. PubMed ID: 3612031
    [No Abstract]   [Full Text] [Related]  

  • 11. Laboratory tests to monitor drug administration.
    Scand J Clin Lab Invest Suppl; 1989; 195():19-21. PubMed ID: 2799278
    [No Abstract]   [Full Text] [Related]  

  • 12. International Federation of Clinical Chemistry (IFCC). Scientific Committee, Clinical Section. Expert Panel on Theory of Reference Values (EPTRV). IFCC Document (1982) stage 2, draft 2, 1983-10-07 with a proposal for an IFCC recommendation. The theory of reference values. Part 2. Selection of individuals for the production of reference values.
    Clin Chim Acta; 1984 May; 139(2):205F-213F. PubMed ID: 6733931
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug effects in clinical chemistry. Part 1. The basic concepts.
    Siest G; Dawkins SJ
    J Clin Chem Clin Biochem; 1984 Mar; 22(3):271-4. PubMed ID: 6726126
    [No Abstract]   [Full Text] [Related]  

  • 14. International Federation of Clinical Chemistry. Scientific Committee, Analytical Section. Expert Panel on Enzymes. IFCC methods for measurement of enzymes. Part 4. IFCC methods for gamma-glutamyltransferase [(gamma-glutamyl)-peptide: amino acid gamma-glutamyltransferase, EC 2.3.2.2]. IFCC Document, Stage 2, Draft 2, 1983-01 with a view to an IFCC Recommendation.
    Shaw LM; Strømme JH; London JL; Theodorsen L
    Clin Chim Acta; 1983 Dec; 135(3):315F-338F. PubMed ID: 6141014
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of various international guidelines for analytical method validation.
    Chandran S; Singh RS
    Pharmazie; 2007 Jan; 62(1):4-14. PubMed ID: 17294806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality control, current need of laboratories of clinical chemistry].
    Grisler R
    Recenti Prog Med; 1967 Jan; 42(1):33-56. PubMed ID: 5632707
    [No Abstract]   [Full Text] [Related]  

  • 17. Descriptive analytical data and consequences for calculation of common reference intervals in the Nordic Reference Interval Project 2000.
    Rustad P; Felding P; Lahti A; Hyltoft Petersen P
    Scand J Clin Lab Invest; 2004; 64(4):343-70. PubMed ID: 15223700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vitamins and clinical chemical tests--small things may have big consequences].
    Kristiansen IS; Førde OH
    Tidsskr Nor Laegeforen; 1995 Feb; 115(4):466. PubMed ID: 7871501
    [No Abstract]   [Full Text] [Related]  

  • 19. International Federation of Clinical Chemistry (IFCC), Scientific Committee, Analytical Section. Guidelines (1985) for classification, calculation and evaluation of conversion rates in clinical chemistry.
    Bechtler G; Haeckel R; Hørder M; Küffer H; Porth AJ
    J Clin Chem Clin Biochem; 1985 Aug; 23(8):493-503. PubMed ID: 4056664
    [No Abstract]   [Full Text] [Related]  

  • 20. Keynote review: in vitro safety pharmacology profiling: an essential tool for successful drug development.
    Whitebread S; Hamon J; Bojanic D; Urban L
    Drug Discov Today; 2005 Nov; 10(21):1421-33. PubMed ID: 16243262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.